Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatric Endocrinology · Congenital Lipoid Adrenal Hyperplasia Due to STAR Deficiency

Puberty, Fertility, and Long-Term Monitoring

At a Glance

Children with STAR deficiency need individualized lifelong follow-up for puberty, fertility, gonad health, growth, bones, blood pressure, and glucose. Puberty and reproductive options vary by chromosome pattern, disease form, anatomy, and remaining hormone function.

As children with STAR deficiency (Lipoid CAH) grow, their medical needs shift from the immediate stabilization of infancy to the long-term goals of supporting a healthy puberty and monitoring for potential complications. Because this condition is rare and complex, your child’s care will require a partnership between you and a multidisciplinary medical team [1][2].

Puberty in 46,XX Children

For girls and children with 46,XX chromosomes, puberty often begins naturally. The brain sends signals to the ovaries, which may still be able to produce enough estrogen to trigger breast development (thelarche) and the start of periods (menarche) [1][3].

However, the “Two-Hit Hypothesis” (the buildup of fats in the cells) also affects the ovaries over time [4]. This leads to two specific long-term risks:

  • Ovarian Cysts: Some children develop cysts on their ovaries [4]. In some cases, these cysts can become large enough to cause torsion (twisting of the ovary), which is an emergency. If sudden, severe one-sided pelvic or abdominal pain occurs, often with nausea or vomiting, seek urgent emergency evaluation [4][1].
  • Premature Ovarian Insufficiency (POI): Because the ovarian cells can be gradually damaged by lipid buildup, the ovaries may “wear out” much earlier than usual, leading to early menopause [3][4].

Puberty in 46,XY Children

For children with 46,XY chromosomes, the pubertal journey depends heavily on their specific anatomy and whether they have the “classic” or “non-classic” form of the disease [5][6]. Use of anatomy-specific, identity-neutral language is important, as decisions require shared decision-making.

  • Classic Form: In classic disease, testes may be unable to provide adequate sex-steroid production. Depending on gonadal function, gonad management, and the individual’s care plan, they may require Hormone Replacement Therapy (HRT)—usually estrogen—to start and maintain puberty [7].
  • Non-classic Form: Some 46,XY children with the non-classic form retain enough protein function to produce their own testosterone. These children may go through a natural male puberty [6][1].
  • Gonad Management: Decisions about internal gonads (testes) require shared decision-making. A multidisciplinary team will help you weigh the benefits of keeping them against the risks, such as the age- and location-dependent risk of germ-cell neoplasia (tumor development) if the gonads are located inside the abdomen [5].

Fertility and Family Planning

The ability to have biological children varies by individual, and options require individualized reproductive-endocrinology counseling.

  • Natural Conception: This has been documented in some individuals with non-classic STAR deficiency [3].
  • Assisted Reproduction: Technologies like In Vitro Fertilization (IVF) and egg or sperm freezing offer possibilities. However, feasibility depends on ovarian reserve, testicular function, anatomy, age, and local access; these are possibilities rather than expected universal options [8][3].
  • Sperm Production: Some 46,XY males with the non-classic form have been found to have typical sperm counts in adulthood [6].

Long-Term Health Monitoring

Because your child will take steroid medications (hydrocortisone and fludrocortisone) for their entire life, their care team must monitor for potential effects of chronic glucocorticoid exposure versus physiologic replacement.

  1. Bone Health: Doctors use Bone Age X-rays to assess skeletal maturation and remaining growth potential [9]. DEXA scans assess bone mineral density, but these are generally reserved for specific risk factors or clinical concerns rather than being automatically required for every child receiving physiologic hydrocortisone [10].
  2. Metabolic Health: High doses of steroids can increase the risk of weight gain, high blood pressure (hypertension), and high blood sugar [11][12]. Regular checks of blood pressure and glucose levels are standard care [10].
  3. Growth Tracking: One of the best “labs” for monitoring treatment is the growth chart. A steady growth curve is often a better sign of correct dosing than any single blood test [11].

As your child moves toward adulthood, your care team will help them “transition” to adult endocrinology, ensuring they have the tools and knowledge to manage their health independently [1][2]. While STAR deficiency requires lifelong attention, with careful monitoring, your child can look forward to a healthy and fulfilling adult life.

Common questions in this guide

Will my child with STAR deficiency go through puberty naturally?
Many children with 46,XX chromosomes begin puberty naturally because their ovaries may produce enough estrogen. In children with 46,XY chromosomes, puberty depends on whether the condition is classic or non-classic, gonadal function, anatomy, and the care plan; some need hormone replacement, while some with non-classic disease may produce enough testosterone for natural puberty.
Can STAR deficiency affect my child’s future fertility?
Fertility varies widely between individuals with STAR deficiency. Natural conception and typical adult sperm counts have been reported in some people with non-classic disease, while in vitro fertilization or egg and sperm freezing may be options for selected individuals.
Why might my child need monitoring for ovarian cysts?
Lipid buildup can affect the ovaries and may lead to ovarian cysts. A large cyst can sometimes cause ovarian torsion, so sudden severe one-sided pelvic or abdominal pain, especially with nausea or vomiting, requires urgent medical evaluation.
How are internal gonads managed in a child with 46,XY chromosomes?
Gonad management is individualized through shared decision-making with a multidisciplinary team. The team weighs the potential benefits of keeping the gonads against risks such as germ-cell tumor development, particularly when the gonads are located inside the abdomen.
How is lifelong steroid treatment monitored in STAR deficiency?
Care teams follow the child’s growth chart, bone age, blood pressure, and blood glucose to assess treatment and watch for excess steroid effects. Bone-density scans are generally used when specific risk factors or clinical concerns are present rather than automatically for every child receiving physiologic hydrocortisone.
When should we discuss fertility preservation for STAR deficiency?
There is no single age that applies to every child, so fertility preservation should be discussed with a reproductive endocrinology team as part of individualized planning. Options depend on ovarian reserve, testicular function, anatomy, age, and local access to care.

Get notified when new evidence is published on Congenital lipoid adrenal hyperplasia due to STAR deficency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Clinical Characteristics and Outcomes of Korean Patients with Lipoid Congenital Adrenal Hyperplasia: An Analysis of Data from the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) Cohort Study.

    Lee Y, Kim M, Lee YJ, et al.

    Endocrinology and metabolism (Seoul, Korea) 2026; (41(4)):566-578 doi:10.3803/EnM.2025.2611.

    PMID: 42190700
  2. 2

    Transition from Pediatric to Adult Endocrine Care in Patients with Congenital Adrenal Hyperplasia: A Single-Center Retrospective Analysis.

    Mercan Sarıdaş F, Karatoprak K, Nursoy H, et al.

    Medicina (Kaunas, Lithuania) 2026; (62(9)) doi:10.3390/medicina62091755.

    PMID: 42796361
  3. 3

    Pubertal Development and Pregnancy Outcomes in 46,XX Patients With Nonclassic Lipoid Congenital Adrenal Hyperplasia.

    Hatabu N, Amano N, Mori J, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(5)):1866-1870 doi:10.1210/jc.2018-01752.

    PMID: 30476142
  4. 4

    Gonadotropin-Releasing Hormone Analog Followed by Sex Hormone Therapy as a Preventive Strategy against Ovarian Complications in Congenital Lipoid Adrenal Hyperplasia: A Case Report.

    Ishii T, Shindo J, Hashimoto N, et al.

    Hormone research in paediatrics 2026; 1-8 doi:10.1159/000553134.

    PMID: 42301958
  5. 5

    Steroidogenic acute regulatory protein (STAR) deficiency: Our experience and systematic review for phenotype-genotype correlation.

    Phadte A, Dhole C, Hegishte S, et al.

    Clinical endocrinology 2024; (100(5)):431-440 doi:10.1111/cen.15032.

    PMID: 38368602
  6. 6

    Pubertal and Adult Testicular Functions in Nonclassic Lipoid Congenital Adrenal Hyperplasia: A Case Series and Review.

    Ishii T, Hori N, Amano N, et al.

    Journal of the Endocrine Society 2019; (3(7)):1367-1374 doi:10.1210/js.2019-00086.

    PMID: 31286101
  7. 7

    Adrenal Crisis in an Adult Patient With Lipoid Congenital Adrenal Hyperplasia due to STAR Protein Mutation.

    Zavgorodneva Z, Kaljevic M, Chen K

    AACE endocrinology and diabetes 2026; (13(5)):788-791 doi:10.1016/j.aed.2026.04.016.

    PMID: 42978993
  8. 8

    Successful IVF pregnancy despite inadequate ovarian steroidogenesis due to congenital lipoid adrenal hyperplasia (CLAH): a case report.

    Albarel F, Perrin J, Jegaden M, et al.

    Human reproduction (Oxford, England) 2016; (31(11)):2609-2612 doi:10.1093/humrep/dew239.

    PMID: 27698074
  9. 9

    Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis.

    Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, Falhammar H

    Frontiers in endocrinology 2020; (11()):493 doi:10.3389/fendo.2020.00493.

    PMID: 32903805
  10. 10

    Congenital adrenal hyperplasia in children: a comprehensive review of clinical spectrum, diagnostic strategies, and management approaches.

    Giri D, Alderson J, Bashir M, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(10)):961-976 doi:10.1515/jpem-2026-0106.

    PMID: 42560052
  11. 11

    Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

    Engberg H, Nordenström A, Hirschberg AL

    The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S37-S45 doi:10.1210/clinem/dgae696.

    PMID: 39836618
  12. 12

    Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study.

    Bacila I, Lawrence NR, Mahdi S, et al.

    European journal of endocrinology 2022; (187(4)):543-553 doi:10.1530/EJE-21-1109.

    PMID: 36001026

This page explains puberty, fertility, and long-term monitoring in STAR deficiency for informational purposes only and does not constitute medical advice. Your child’s endocrinology team should tailor hormone treatment, gonad management, and follow-up to their individual needs.